172 related articles for article (PubMed ID: 11490812)
21. Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.
Akanuma M; Yoshida H; Okamoto M; Ogura K; Maeda S; Hata Y; Sato S; Shiina S; Kawabe T; Shiratori Y; Omata M
Hepatogastroenterology; 2002; 49(46):1039-44. PubMed ID: 12143197
[TBL] [Abstract][Full Text] [Related]
22. [Single hepatocellular carcinoma (phi < or = 5 cm) in liver cirrhosis. Early diagnosis and surgical removal].
Paquet KJ; Lazar A; Rambach W; Kuhn R
Chirurg; 1993 Oct; 64(10):784-8. PubMed ID: 8269741
[TBL] [Abstract][Full Text] [Related]
23. Gastrectomy in combination with a distal splenorenal shunt in a patient with gastric cancer and portal hypertension: report of a case.
Kato T; Kato H; Kondo S; Okushiba S; Morikawa T
Surg Today; 2002; 32(8):727-30. PubMed ID: 12181726
[TBL] [Abstract][Full Text] [Related]
24. [Distal splenorenal shunt (Warren's operation) in the treatment of portal hypertension. Apropos 3 cases].
Popescu I; Ionescu M; Tomulescu V
Chirurgia (Bucur); 1996; 45(1):21-5. PubMed ID: 8924784
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
[TBL] [Abstract][Full Text] [Related]
26. Portosystemic shunts in children: a 15-year experience.
Botha JF; Campos BD; Grant WJ; Horslen SP; Sudan DL; Shaw BW; Langnas AN
J Am Coll Surg; 2004 Aug; 199(2):179-85. PubMed ID: 15275870
[TBL] [Abstract][Full Text] [Related]
27. [Effect of combined operation including splenorenal shunt as the main technique for portal hypertension in children].
Li Z; Zhao L; Yu Z; Zhong Z
Zhonghua Wai Ke Za Zhi; 2000 Aug; 38(8):601-3. PubMed ID: 11832118
[TBL] [Abstract][Full Text] [Related]
28. Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Kogo M; Sato N; Yoneyama K; Imawari M; Kiuchi Y
Hepatogastroenterology; 2007; 54(79):2049-54. PubMed ID: 18251158
[TBL] [Abstract][Full Text] [Related]
29. Late clinical, biochemical, endoscopic and electroencephalographic evaluation of patients with schistosomal portal hypertension treated with distal splenorenal shunt.
Lopes Filho Gde J; Haddad CM
Int Surg; 1998; 83(1):42-7. PubMed ID: 9706517
[TBL] [Abstract][Full Text] [Related]
30. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 2003; 50(54):1766-9. PubMed ID: 14696400
[TBL] [Abstract][Full Text] [Related]
31. The distal splenorenal shunt: an update on experience of 106 cases.
Pezzuoli G; Spina G; Santambrogio R; Galeotti F; Opocher E; Cucchiaro G; Lopez C; Strinna M
Int Surg; 1987; 72(3):144-8. PubMed ID: 3679731
[TBL] [Abstract][Full Text] [Related]
32. Survival factors after resection of small hepatocellular carcinoma.
Wu FS; Zhao WH; Liang TB; Ma ZM; Teng LS; Wang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):379-84. PubMed ID: 16109520
[TBL] [Abstract][Full Text] [Related]
33. The jugular vein as an interposition graft in the distal splenorenal shunt.
Rosenthal D; Barber WA; Lamis PA; Jones DH; Stanton PE
Surg Gynecol Obstet; 1985 Oct; 161(4):372-4. PubMed ID: 4049207
[TBL] [Abstract][Full Text] [Related]
34. Small-diameter H-graft portacaval shunt for variceal hemorrhage: experience at King Chulalongkorn Memorial Hospital.
Sriussadaporn S; Pak-art R; Sriussadaporn S
J Med Assoc Thai; 2004 Apr; 87(4):427-31. PubMed ID: 15217183
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of hepatocellular carcinoma associated with spontaneous portosystemic shunts.
Hayashi T; Kohno H; Yamanoi A; Kubota H; Tachibana M; Nagasue N
Eur J Surg; 1999 Jun; 165(6):543-9. PubMed ID: 10433137
[TBL] [Abstract][Full Text] [Related]
36. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding.
Lang BH; Poon RT; Fan ST; Wong J
Am J Gastroenterol; 2004 Nov; 99(11):2158-65. PubMed ID: 15554997
[TBL] [Abstract][Full Text] [Related]
38. Splenoadrenal shunt. An original portosystemic decompressive technique.
Jovine E; Cescon M; Ercolani G; Masetti M; Mazziotti A; Cavallari A
Hepatogastroenterology; 2001; 48(37):107-8. PubMed ID: 11268941
[TBL] [Abstract][Full Text] [Related]
39. Effect of distal splenorenal shunt plus splenopancreatic disconnection on glucose and amino acid metabolism.
Hashimoto N; Ashida H
Hepatogastroenterology; 2005; 52(61):274-6. PubMed ID: 15783048
[TBL] [Abstract][Full Text] [Related]
40. Results of modified Sugiura operation in variceal bleeding in cirrhotic and noncirrhotic patients.
Haciyanli M; Genc H; Halici H; Kumkumoglu Y; Gur OS; Ozturk T
Hepatogastroenterology; 2003; 50(51):784-8. PubMed ID: 12828085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
